Asymmetric Catalysis in the Pharmaceutical Industry
- 16 June 2004
- journal article
- review article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 43 (25), 3224-3228
- https://doi.org/10.1002/anie.200330072
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- In Situ Recycling of Chiral Ligand and Surplus Nucleophile for a Noncatalytic Reaction: Amplification of Process Throughput in the Asymmetric Addition Step of Efavirenz (DMP 266)Organic Process Research & Development, 2003
- Large-Scale Candoxatril Asymmetric HydrogenationOrganic Process Research & Development, 2001
- Me-DuPHOS-Rh-Catalyzed Asymmetric Synthesis of the Pivotal Glutarate Intermediate for CandoxatrilThe Journal of Organic Chemistry, 1999
- Stereoselective synthesis of a candoxatril intermediate
- Racematspaltungen mit SubstanzfamilienAngewandte Chemie, 1998
- General Strategy toward the Tetrahydronaphthalene Skeleton. An Expedient Total Synthesis of SertralineThe Journal of Organic Chemistry, 1997
- Synthesis of Chiral 2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl (BINAP) via a Novel Nickel-Catalyzed Phosphine InsertionThe Journal of Organic Chemistry, 1994
- A catalytic enantioselective synthetic route to the important antidepressant sertralineTetrahedron Letters, 1994
- Synthesis of 4(S)-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone by SN2 cuprate displacement of an activated chiral benzylic alcoholTetrahedron, 1992
- Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralinsJournal of Medicinal Chemistry, 1984